Savara Inc. Files 8-K: Material Definitive Agreement
Ticker: SVRA · Form: 8-K · Filed: Jun 28, 2024 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | 8-K |
| Filed Date | Jun 28, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $3.81 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-action
TL;DR
Savara Inc. signed a big deal, details TBD.
AI Summary
On June 27, 2024, Savara Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company, formerly known as Mast Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates a significant new agreement for Savara Inc., which could impact its future operations and financial standing. Investors should monitor for further details regarding the nature and terms of this agreement.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, but the lack of specific details about the agreement introduces uncertainty and potential risk.
Key Numbers
- 001-32157 — Commission File Number (Identifies Savara Inc.'s filing with the SEC)
- 84-1318182 — IRS Employer Identification No. (Tax identification for Savara Inc.)
Key Players & Entities
- Savara Inc. (company) — Registrant
- Mast Therapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- June 27, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the Material Definitive Agreement entered into by Savara Inc. on June 27, 2024?
The filing does not disclose the specific details of the Material Definitive Agreement, only that one was entered into on June 27, 2024.
What was Savara Inc.'s former company name?
Savara Inc.'s former company name was Mast Therapeutics, Inc., with a name change date of March 12, 2013.
In which state is Savara Inc. incorporated?
Savara Inc. is incorporated in Delaware.
What is Savara Inc.'s fiscal year end?
Savara Inc.'s fiscal year ends on December 31.
What is the SIC code for Savara Inc.?
The Standard Industrial Classification (SIC) code for Savara Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 777 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2024-06-28 10:10:54
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share SVRA The Nasdaq Global Se
- $3.81 — "). The offering price of the Shares is $3.81 per share. The Offering is expected to
Filing Documents
- d756853d8k.htm (8-K) — 28KB
- d756853dex11.htm (EX-1.1) — 228KB
- d756853dex51.htm (EX-5.1) — 10KB
- d756853dex991.htm (EX-99.1) — 9KB
- g756853dsp001.jpg (GRAPHIC) — 16KB
- g756853g0628085622558.jpg (GRAPHIC) — 4KB
- g756853g0628105633594.jpg (GRAPHIC) — 5KB
- 0001193125-24-171564.txt ( ) — 495KB
- svra-20240627.xsd (EX-101.SCH) — 3KB
- svra-20240627_lab.xml (EX-101.LAB) — 17KB
- svra-20240627_pre.xml (EX-101.PRE) — 11KB
- d756853d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated June 27, 2024, by and among Savara Inc., Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein 5.1 Opinion of Holland & Knight LLP 99.1 Press Release of Savara Inc., dated June 28, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 28, 2024 SAVARA INC. a Delaware corporation By: /s/ Dave Lowrance Dave Lowrance Chief Financial & Administrative Officer